Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 287

1.

Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials.

McIntyre WF, Connolly SJ, Wang J, Masiero S, Benz AP, Conen D, Wong JA, Beresh H, Healey JS.

Eur Heart J. 2019 Aug 4. pii: ehz521. doi: 10.1093/eurheartj/ehz521. [Epub ahead of print]

PMID:
31377776
2.

Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group.

Boriani G, Healey JS, Schnabel RB, Lopes RD, Calkins H, Camm JA, Freedman B.

Int J Cardiol. 2019 Jul 11. pii: S0167-5273(19)32817-7. doi: 10.1016/j.ijcard.2019.07.039. [Epub ahead of print]

PMID:
31327519
3.

Vernakalant for cardioversion of recent-onset atrial fibrillation: a systematic review and meta-analysis.

McIntyre WF, Healey JS, Bhatnagar AK, Wang P, Gordon JA, Baranchuk A, Deif B, Whitlock RP, Belley-Côté ÉP.

Europace. 2019 Jul 10. pii: euz175. doi: 10.1093/europace/euz175. [Epub ahead of print]

PMID:
31292622
4.

Screening for Atrial Fibrillation Using a Mobile, Single-Lead Electrocardiogram in Canadian Primary Care Clinics.

Godin R, Yeung C, Baranchuk A, Guerra P, Healey JS.

Can J Cardiol. 2019 Jul;35(7):840-845. doi: 10.1016/j.cjca.2019.03.024. Epub 2019 Apr 6.

PMID:
31292082
5.

Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy.

Roberts JD, Murphy NP, Hamilton RM, Lubbers ER, James CA, Kline CF, Gollob MH, Krahn AD, Sturm AC, Musa H, El-Refaey M, Koenig S, Aneq MÅ, Hoorntje ET, Graw SL, Davies RW, Rafiq MA, Koopmann TT, Aafaqi S, Fatah M, Chiasson DA, Taylor MR, Simmons SL, Han M, van Opbergen CJ, Wold LE, Sinagra G, Mittal K, Tichnell C, Murray B, Codima A, Nazer B, Nguyen DT, Marcus FI, Sobriera N, Lodder EM, van den Berg MP, Spears DA, Robinson JF, Ursell PC, Green AK, Skanes AC, Tang AS, Gardner MJ, Hegele RA, van Veen TA, Wilde AA, Healey JS, Janssen PM, Mestroni L, van Tintelen JP, Calkins H, Judge DP, Hund TJ, Scheinman MM, Mohler PJ.

J Clin Invest. 2019 Jul 2;129(8):3171-3184. doi: 10.1172/JCI125538. eCollection 2019 Jul 2.

6.

Clinical Outcomes in Atrial Fibrillation Research: Shining a Light on a New Path.

Healey JS, Carroll SL.

JACC Clin Electrophysiol. 2019 May;5(5):606-607. doi: 10.1016/j.jacep.2019.03.016. No abstract available.

PMID:
31122383
7.

Concomitant anti-platelet therapy in warfarin-treated patients undergoing cardiac rhythm device implantation: A secondary analysis of the BRUISE CONTROL trial.

Essebag V, AlTurki A, Proietti R, Healey JS, Wells GA, Verma A, Krahn AD, Simpson CS, Ayala-Paredes F, Coutu B, Leather R, Ahmad K, Toal S, Sapp J, Sturmer M, Kavanagh K, Crystal E, Leiria TLL, Seifer C, Rinne C, Birnie D; BRUISE CONTROL Investigators.

Int J Cardiol. 2019 Aug 1;288:87-93. doi: 10.1016/j.ijcard.2019.04.066. Epub 2019 Apr 26.

PMID:
31056413
8.

Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined HF Population: The GENETIC-AF Trial.

Piccini JP, Abraham WT, Dufton C, Carroll IA, Healey JS, van Veldhuisen DJ, Sauer WH, Anand IS, White M, Wilton SB, Aleong R, Rienstra M, Krueger SK, Ayala-Paredes F, Khaykin Y, Merkely B, Miloradović V, Wranicz JK, Ilkhanoff L, Ziegler PD, Davis G, Emery LL, Marshall D, Kao DP, Bristow MR, Connolly SJ; GENETIC-AF Trial Investigators.

JACC Heart Fail. 2019 Jul;7(7):586-598. doi: 10.1016/j.jchf.2019.04.004. Epub 2019 Apr 29.

PMID:
31042551
9.

Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome.

Cheung CC, Mellor G, Deyell MW, Ensam B, Batchvarov V, Papadakis M, Roberts JD, Leather R, Sanatani S, Healey JS, Chauhan VS, Birnie DH, Champagne J, Angaran P, Klein GJ, Yee R, Simpson CS, Talajic M, Gardner M, Yeung-Lai-Wah JA, Chakrabarti S, Laksman ZW, Sharma S, Behr ER, Krahn AD.

JACC Clin Electrophysiol. 2019 Apr;5(4):504-512. doi: 10.1016/j.jacep.2019.01.026. Epub 2019 Mar 27.

PMID:
31000106
10.

Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical Trial.

Healey JS, Gladstone DJ, Swaminathan B, Eckstein J, Mundl H, Epstein AE, Haeusler KG, Mikulik R, Kasner SE, Toni D, Arauz A, Ntaios G, Hankey GJ, Perera K, Pagola J, Shuaib A, Lutsep H, Yang X, Uchiyama S, Endres M, Coutts SB, Karlinski M, Czlonkowska A, Molina CA, Santo G, Berkowitz SD, Hart RG, Connolly SJ.

JAMA Neurol. 2019 Jul 1;76(7):764-773. doi: 10.1001/jamaneurol.2019.0617.

PMID:
30958508
11.

Effectiveness of single- vs dual-coil implantable defibrillator leads: An observational analysis from the SIMPLE study.

Neuzner J, Hohnloser SH, Kutyifa V, Glikson M, Dietze T, Mabo P, Vinolas X, Kautzner J, O'Hara G, Lawo T, Brachmann J, VanErven L, Gadler F, Appl U, Wang J, Connolly SJ, Healey JS.

J Cardiovasc Electrophysiol. 2019 Jul;30(7):1078-1085. doi: 10.1111/jce.13943. Epub 2019 Apr 22.

PMID:
30945798
12.

Challenge and Impact of Quinidine Access in Sudden Death Syndromes: A National Experience.

Malhi N, Cheung CC, Deif B, Roberts JD, Gula LJ, Green MS, Pang B, Sultan O, Konieczny KM, Angaran P, Dorian P, Lashevsky I, Healey JS, Alak A, Tadros R, Andorin A, Steinberg C, Ayala-Paredes F, Simpson CS, Atallah J, Krahn AD.

JACC Clin Electrophysiol. 2019 Mar;5(3):376-382. doi: 10.1016/j.jacep.2018.10.007. Epub 2018 Nov 28.

PMID:
30898241
13.

The RACE to Treat Atrial Fibrillation in the Emergency Department.

Healey JS, McIntyre WF.

N Engl J Med. 2019 Apr 18;380(16):1578-1579. doi: 10.1056/NEJMe1902341. Epub 2019 Mar 18. No abstract available.

PMID:
30883049
14.

Pre- and post-treatment with amiodarone for elective electrical cardioversion of atrial fibrillation: a systematic review and meta-analysis.

Um KJ, McIntyre WF, Healey JS, Mendoza PA, Koziarz A, Amit G, Chu VA, Whitlock RP, Belley-Côté EP.

Europace. 2019 Jun 1;21(6):856-863. doi: 10.1093/europace/euy310. Erratum in: Europace. 2019 Jun 1;21(6):863.

PMID:
30875422
15.

Prospective Study of Tricuspid Regurgitation Associated With Permanent Leads After Cardiac Rhythm Device Implantation.

Van De Heyning CM, Elbarasi E, Masiero S, Brambatti M, Ghazal S, Al-Maashani S, Capucci A, Leong D, Shivalkar B, Saenen JB, Miljoen HP, Morillo CA, Divarakarmenon S, Amit G, Ribas S, Baiocco E, Maolo A, Romandini A, Maffei S, Connolly SJ, Healey JS, Dokainish H.

Can J Cardiol. 2019 Apr;35(4):389-395. doi: 10.1016/j.cjca.2018.11.014. Epub 2018 Nov 29.

PMID:
30852048
16.

Reasons for hospitalization and risk of mortality in patients with atrial fibrillation treated with dabigatran or warfarin in the Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial.

Alak A, Hohnloser SH, Fräßdorf M, Reilly P, Ezekowitz M, Healey JS, Brueckmann M, Yusuf S, Connolly SJ.

Europace. 2019 Mar 8. pii: euz021. doi: 10.1093/europace/euz021. [Epub ahead of print]

PMID:
30848783
17.

A Call for Randomized Trials of Oral Anticoagulation for Patients With Post-Operative Atrial Fibrillation.

McIntyre WF, Healey JS, Devereaux PJ, Conen D.

J Am Coll Cardiol. 2019 Mar 12;73(9):1105. doi: 10.1016/j.jacc.2018.11.057. No abstract available.

PMID:
30846108
18.

Phospholamban cardiomyopathy: a Canadian perspective on a unique population.

Cheung CC, Healey JS, Hamilton R, Spears D, Gollob MH, Mellor G, Steinberg C, Sanatani S, Laksman ZW, Krahn AD.

Neth Heart J. 2019 Apr;27(4):208-213. doi: 10.1007/s12471-019-1247-0.

19.

Stroke prevention in atrial fibrillation: Closing the gap.

Pokorney SD, Gersh BJ, Ahmad A, Al-Khatib SM, Blank M, Coylewright M, DiBattiste P, Healey JS, Hedrich O, Hylek EM, Kline-Rogers E, Peterson ED, Mendys P, Mirro MJ, Naccarelli G, Patel P, Ruff CT, Rutman H, Stockbridge N, Temple R, Granger CB.

Am Heart J. 2019 Apr;210:29-38. doi: 10.1016/j.ahj.2018.10.004. Epub 2018 Oct 25. No abstract available.

PMID:
30731371
20.

Canadian Nephrologist Views Regarding Stroke and Systemic Embolism Prevention in Dialysis Patients With Nonvalvular Atrial Fibrillation: A Survey.

Collister D, Healey JS, Conen D, Brimble KS, Rigatto C, Harel Z, Sood MM, Walsh M.

Can J Kidney Health Dis. 2019 Jan 8;6:2054358118821945. doi: 10.1177/2054358118821945. eCollection 2019.

21.

Descriptive analysis of pharmacy services provided after community pharmacy screening.

Lancaster K, Thabane L, Tarride JE, Agarwal G, Healey JS, Sandhu R, Dolovich L.

Int J Clin Pharm. 2018 Dec;40(6):1577-1586. doi: 10.1007/s11096-018-0742-5. Epub 2018 Nov 26.

22.

Early Repolarization Pattern Inheritance in the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER).

Malhi N, So PP, Cheung CC, Laksman ZWM, Healey JS, Chauhan VS, Green MS, Champagne J, Steinberg C, Sanatani S, Angaran P, Duff H, Roberts JD, Arbour L, Leather R, Simpson CS, Tadros R, Talajic M, Gardner M, Siefer C, Krahn AD.

JACC Clin Electrophysiol. 2018 Nov;4(11):1473-1479. doi: 10.1016/j.jacep.2018.07.001. Epub 2018 Aug 29.

PMID:
30466855
23.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).

Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.

Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.

PMID:
30462279
24.

Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.

Healey JS, Wong J.

Europace. 2019 Mar 1;21(3):377-382. doi: 10.1093/europace/euy246.

PMID:
30418608
25.

The Guideline-Policy Gap in Direct-Acting Oral Anticoagulants Usage in Atrial Fibrillation: Evidence, Practice, and Public Policy Considerations.

Wan D, Healey JS, Simpson CS.

Can J Cardiol. 2018 Nov;34(11):1412-1425. doi: 10.1016/j.cjca.2018.07.476. Review.

PMID:
30404747
26.

2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.

Andrade JG, Verma A, Mitchell LB, Parkash R, Leblanc K, Atzema C, Healey JS, Bell A, Cairns J, Connolly S, Cox J, Dorian P, Gladstone D, McMurtry MS, Nair GM, Pilote L, Sarrazin JF, Sharma M, Skanes A, Talajic M, Tsang T, Verma S, Wyse DG, Nattel S, Macle L; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2018 Nov;34(11):1371-1392. doi: 10.1016/j.cjca.2018.08.026. Review.

PMID:
30404743
27.

Atrial fibrillation detected initially during acute medical illness: A systematic review.

McIntyre WF, Um KJ, Cheung CC, Belley-Côté EP, Dingwall O, Devereaux PJ, Wong JA, Conen D, Whitlock RP, Connolly SJ, Seifer CM, Healey JS.

Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):130-141. doi: 10.1177/2048872618799748. Epub 2018 Nov 7.

PMID:
30403364
28.

Rationale and design of the randomized prospective ATLAS study: Avoid Transvenous Leads in Appropriate Subjects.

Mondésert B, Bashir J, Philippon F, Dubuc M, Amit G, Exner D, Joza J, Birnie DH, Lane C, Tsang B, Korley V, Spears D, Ling A, Djuric A, Crystal E, Hruczkowski T, Roux JF, Carroll S, Essebag V, Krahn AD, Healey JS.

Am Heart J. 2019 Jan;207:1-9. doi: 10.1016/j.ahj.2018.09.008. Epub 2018 Oct 9.

PMID:
30399474
29.

Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta-analysis.

AlTurki A, Huynh T, Dawas A, AlTurki H, Joza J, Healey JS, Essebag V.

J Arrhythm. 2018 Jul 20;34(5):478-484. doi: 10.1002/joa3.12095. eCollection 2018 Oct. Review.

30.

"I don't know exactly what you're referring to": the challenge of values elicitation in decision making for implantable cardioverter-defibrillators.

Carroll SL, Embuldeniya G, Pannag J, Lewis KB, Healey JS, McGillion M, Thabane L, Stacey D.

Patient Prefer Adherence. 2018 Sep 28;12:1947-1954. doi: 10.2147/PPA.S173705. eCollection 2018.

31.

Perspective and practice of surgical atrial fibrillation ablation: an international survey of cardiac surgeons.

Belley-Cote EP, Singal RK, McClure G, Devereaux K, Brady K, An K, Healey JS, Connolly SJ, Whitlock RP.

Europace. 2019 Mar 1;21(3):445-450. doi: 10.1093/europace/euy212.

PMID:
30304396
32.

Prevention of venous thrombosis after electrophysiology procedures: a survey of national practice.

Burstein B, Barbosa RS, Samuel M, Kalfon E, Philippon F, Birnie D, Mangat I, Redfearn D, Sandhu R, Macle L, Sapp J, Verma A, Healey JS, Becker G, Chauhan V, Coutu B, Roux JF, Leong-Sit P, Andrade JG, Veenhuyzen GD, Joza J, Bernier M, Essebag V.

J Interv Card Electrophysiol. 2018 Dec;53(3):357-363. doi: 10.1007/s10840-018-0461-9. Epub 2018 Oct 8.

PMID:
30298364
33.

An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis.

Chatterjee D, Fatah M, Akdis D, Spears DA, Koopmann TT, Mittal K, Rafiq MA, Cattanach BM, Zhao Q, Healey JS, Ackerman MJ, Bos JM, Sun Y, Maynes JT, Brunckhorst C, Medeiros-Domingo A, Duru F, Saguner AM, Hamilton RM.

Eur Heart J. 2018 Nov 21;39(44):3932-3944. doi: 10.1093/eurheartj/ehy567.

PMID:
30239670
34.

Is Screening for Atrial Fibrillation in Canadian Family Practices Cost-Effective in Patients 65 Years and Older?

Tarride JE, Quinn FR, Blackhouse G, Sandhu RK, Burke N, Gladstone DJ, Ivers NM, Dolovich L, Thornton A, Nakamya J, Ramasundarahettige C, Frydrych PA, Henein S, Ng K, Congdon V, Birtwhistle RV, Ward R, Healey JS.

Can J Cardiol. 2018 Nov;34(11):1522-1525. doi: 10.1016/j.cjca.2018.05.016. Epub 2018 Jun 21.

35.

Design and rationale of the atrial fibrillation occurring transiently with stress (AFOTS) follow-up cohort study.

McIntyre WF, Mendoza PA, Belley-Côté EP, Whitlock RP, Um KJ, Maystrenko N, Devereaux PJ, Conen D, Wong JA, Connolly SJ, Healey JS.

Clin Cardiol. 2018 Oct;41(10):1273-1280. doi: 10.1002/clc.23053. Epub 2018 Oct 18.

36.

Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation.

McAlister FA, Wiebe N, Ronksley PE, Healey JS.

Int J Cardiol. 2018 Oct 15;269:145-151. doi: 10.1016/j.ijcard.2018.07.128. Epub 2018 Jul 27.

37.

Diagnostic accuracy and yield of screening tests for atrial fibrillation in the family practice setting: a multicentre cohort study.

Quinn FR, Gladstone DJ, Ivers NM, Sandhu RK, Dolovich L, Ling A, Nakamya J, Ramasundarahettige C, Frydrych PA, Henein S, Ng K, Congdon V, Birtwhistle RV, Ward R, Healey JS.

CMAJ Open. 2018 Aug 2;6(3):E308-E315. doi: 10.9778/cmajo.20180001. Print 2018 Jul-Sep.

38.

Limitations of Administrative Data for Examining Secondary Atrial Fibrillation.

Um KJ, Belley-Côté EP, Healey JS, McIntyre WF.

JACC Clin Electrophysiol. 2018 Apr;4(4):561-562. doi: 10.1016/j.jacep.2017.12.021. No abstract available.

39.

Defibrillation testing and clinical outcomes after implantable cardioverter-defibrillator implantation in patients in atrial fibrillation at the time of implant: An analysis from the SIMPLE trial.

Bogdan S, Glikson M, Connolly SJ, Wang J, Hohnloser SH, Appl U, Neuzener J, Mabo P, Vinolas X, Gadler F, van Erven L, Kautzner J, Meeks B, Pogue J, Healey JS.

Heart Rhythm. 2019 Jan;16(1):83-90. doi: 10.1016/j.hrthm.2018.07.030. Epub 2018 Jul 29.

PMID:
30063996
40.

Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients.

Shurrab M, Ko DT, Zayed Y, Navaneethan SD, Yadak N, Yaseen A, Kaoutskaia A, Qamhia W, Hamdan Z, Haj-Yahia S, Lee DS, Newman D, Healey JS, Harvey P, Crystal E.

J Interv Card Electrophysiol. 2018 Oct;53(1):123-129. doi: 10.1007/s10840-018-0424-1. Epub 2018 Jul 30. Review.

PMID:
30058056
41.

Cardiac resynchronization is pro-arrhythmic in the absence of reverse ventricular remodelling: a systematic review and meta-analysis.

Deif B, Ballantyne B, Almehmadi F, Mikhail M, McIntyre WF, Manlucu J, Yee R, Sapp JL, Roberts JD, Healey JS, Leong-Sit P, Tang AS.

Cardiovasc Res. 2018 Sep 1;114(11):1435-1444. doi: 10.1093/cvr/cvy182.

PMID:
30010807
42.

Stroke Prevention in Atrial Fibrillation: What Is Real World, and What Do Real-World Data Reveal?

Healey JS.

J Am Coll Cardiol. 2018 Jul 10;72(2):154-155. doi: 10.1016/j.jacc.2018.04.057. No abstract available.

43.

Screening for undiagnosed atrial fibrillation.

Sandhu RK, Healey JS.

Expert Rev Cardiovasc Ther. 2018 Aug;16(8):591-598. doi: 10.1080/14779072.2018.1496018. Epub 2018 Jul 16. Review.

PMID:
29963930
44.

Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.

Wong JA, Conen D, Van Gelder IC, McIntyre WF, Crijns HJ, Wang J, Gold MR, Hohnloser SH, Lau CP, Capucci A, Botto G, Grönefeld G, Israel CW, Connolly SJ, Healey JS.

J Am Coll Cardiol. 2018 Jun 12;71(23):2603-2611. doi: 10.1016/j.jacc.2018.03.519.

45.

Sedation strategies for defibrillation threshold testing: safety outcomes with anaesthesiologist compared to proceduralist-directed sedation: an analysis from the SIMPLE study.

Sandhu RK, Quadros KK, Liu YY, Glikson M, Kutyifa V, Mabo P, Hohnloser S, O'Hara G, VanErven L, Neuzner J, Kautzner J, Gadler F, Vinolas X, Appl U, Connolly SJ, Healey JS.

Europace. 2018 Nov 1;20(11):1798-1803. doi: 10.1093/europace/euy114.

PMID:
29878102
46.

Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.

McIntyre WF, Um KJ, Alhazzani W, Lengyel AP, Hajjar L, Gordon AC, Lamontagne F, Healey JS, Whitlock RP, Belley-Côté EP.

JAMA. 2018 May 8;319(18):1889-1900. doi: 10.1001/jama.2018.4528. Review.

47.

Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH Trial.

Coyle K, Coyle D, Nault I, Parkash R, Healey JS, Gray CJ, Gardner MJ, Sterns LD, Essebag V, Hruczkowski T, Blier L, Wells GA, Tang ASL, Stevenson WG, Sapp JL.

JACC Clin Electrophysiol. 2018 May;4(5):660-668. doi: 10.1016/j.jacep.2018.01.007. Epub 2018 Mar 28.

48.

Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.

Brouwer TF, Knops RE, Kutyifa V, Barr C, Mondésert B, Boersma LVA, Lambiase PD, Wold N, Jones PW, Healey JS.

Europace. 2018 Sep 1;20(FI2):f240-f248. doi: 10.1093/europace/euy083.

PMID:
29771327
49.

Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT).

Perera KS, Sharma M, Connolly SJ, Wang J, Gold MR, Hohnloser SH, Lau CP, Van Gelder IC, Morillo C, Capucci A, Israel CW, Botto G, Healey JS.

Am Heart J. 2018 Jul;201:160-163. doi: 10.1016/j.ahj.2018.03.027. Epub 2018 Apr 18.

PMID:
29764671
50.

A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial.

Piccini JP, Connolly SJ, Abraham WT, Healey JS, Steinberg BA, Al-Khalidi HR, Dignacco P, van Veldhuisen DJ, Sauer WH, White M, Wilton SB, Anand IS, Dufton C, Marshall DA, Aleong RG, Davis GW, Clark RL, Emery LL, Bristow MR.

Am Heart J. 2018 May;199:51-58. doi: 10.1016/j.ahj.2017.12.001. Epub 2017 Dec 6.

PMID:
29754666

Supplemental Content

Loading ...
Support Center